Recent News
>> January 10 - PerkinElmer Teams with Luminex to Develop Solutions for High Volume Disease Screening

>> January 5 - Charles River Laboratories Signs Licensing Agreement with Luminex Corporation

>> November 14 - Luminex Corporation Awarded Frost & Sullivan 2005 Clinical Diagnostics Technology of the Year 

>> November 10 - Luminex Partner, Tm Bioscience, Launches Multiplexed Respiratory Test Including Avian Flu and SARS

>> October 26 - Luminex Corporation Reports Third Quarter 2005 Results

>> September 27 - Luminex Corporation Announces Launch of Luminex 200 Instrument

By pioneering a unique approach to biological testing, known as xMAP® technology, Luminex® Corporation (NASDAQ: LMNX) is revolutionizing the life-sciences industry. This groundbreaking technology enables companies and laboratories to perform bioassays far more quickly and cost-effectively than with other systems, while ensuring optimum accuracy. With an already extensive list of applications, xMAP technology offers a world of possibilities — from one tiny drop of sample.   more >>

Updated September 7 - Read a Message from the CEO - Patrick J. Balthrop